Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

373 trials

NCT05102929
Recruiting
Enhancing Prefrontal Oscillations and Working Memory in Early-course Schizophrenia
Not applicable · United States · 1 site
Registry update: 11 Aug 2026
NCT05052853
Recruiting
Early Intervention of Prodromal Schizophrenia Using an NMDA Enhancer
Phase 2 · Taiwan · 1 site
Registry update: 24 Mar 2026
NCT05131035
Recruiting
Targeting Processing Speed Deficits to Improve Social Functioning and Lower Psychosis Risk
Not applicable · United States · 1 site
Registry update: 24 Nov 2025
NCT06634446
Recruiting
Self-administered COgnitive Personalized Training in Early Psychosis
Not applicable · France · 1 site
Registry update: 10 Oct 2024
NCT04946916
Recruiting
Neurofilament Light Chains and Cognitive Impairment in Chronic Psychiatric Disease
Not applicable · France · 2 sites
Registry update: 24 Jul 2025
NCT05343598
Recruiting
Using Transcranial Magnetic Stimulation (TMS) to Understand Hallucinations in Schizophrenia
Not applicable · United States · 1 site
Registry update: 22 Jan 2026
NCT04655235
Recruiting
Translational Investigation of the Glutamatergic and GABAergic System in Schizophrenia
Not applicable · Germany · 3 sites
Registry update: 14 Mar 2025
2023-507372-42-00
Recruiting
A Clinical trial to evaluate the efficacy of vafidemstat in negative symptoms and cognitive impairment associated with schizophrenia. (EVOLUTION study)
Phase 2 · Bulgaria, Spain, Poland, Romania, Slovakia · 40 sites
Registry update: 3 Sept 2026
NCT05025605
Recruiting
Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
Phase 1 · United States · 5 sites
Registry update: 11 Aug 2026
NCT04432116
Recruiting
Time and Virtual Reality in Schizophrenia and Bipolar Disorder
Not applicable · France · 1 site
Registry update: 11 Mar 2026
NCT04366518
Recruiting
Toward a Computationally-Informed, Personalized Treatment for Hallucinations
Early phase 1 · United States · 1 site
Registry update: 5 Jun 2025
NCT04370730
Recruiting
Dimensional and Developmental Profiles of Psychosis in Children and Adolescents
Not applicable · France · 6 sites
Registry update: 23 Jan 2026
NCT04789915
Recruiting
Add-on MEmaNtine to Dopamine Modulation to Improve Negative Symptoms at First Psychosis
Phase 1 · Denmark · 1 site
Registry update: 9 Dec 2024
2024-518042-24-00
Recruiting
An open label signal detection study to evaluate the effects of cariprazine on cognitive functioning in patients with schizophrenia in need of adjustment of oral antipsychotic treatment
Phase 4 · Austria · 2 sites
Registry update: 22 Jun 2026
NCT05316883
Recruiting
Biomarkers in Clozapine-responding Schizophrenia
Phase 4 · Denmark · 1 site
Registry update: 20 Jan 2026
NCT06958341
Recruiting
Neuroimmunology Registry and Biobank
Not applicable · Germany · 2 sites
Registry update: 6 May 2025
NCT04730518
Recruiting
Yoga-based Group Intervention (YoGI) for In-patients With Schizophrenia Spectrum Disorders
Not applicable · Germany · 1 site
Registry update: 24 Feb 2025
NCT04959201
Recruiting
Combination of NMDA-enhancing and Antioxidant Treatments for Schizophrenia
Phase 2 · Taiwan · 1 site
Registry update: 23 Oct 2026
NCT04807530
Recruiting
Medial-prefrontal Enhancement During Schizophrenia Systems Imaging
Not applicable · United States · 1 site
Registry update: 29 Aug 2025
NCT04917302
Recruiting
Combination of NMDA-enhancing and Anti-inflammatory Treatments for Schizophrenia
Phase 2 · Taiwan · 1 site
Registry update: 23 Oct 2026

Ordered by registry start date. Freshness and sponsorship never change the order.